FNF.V. Nenakhov

F.V. Nenakhov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


F.V. Nenakhov has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Heterogeneity of the molecular phenotype with uterine fibroids. Message II

    by E.A. Nersesyan, L.V. Akulenko, M.V. Kuznetsova, A.V. Asaturova, A.S. Badlaeva, T.A. Chernyshenko, F.V. Nenakhov, N.M. Tonoyan, G.V. Mikhailovskaya, K.A. Svirepova, et al.

    The objective of study was expression profiles of 17 candidate genes in cells of morphologically verified myomatous nodes and unchanged myometrium in the associated and non-associated molecular phenotype of uterine fibroids with mutations in the MED12 gene. Material and methods. The research material was presented by 133 tissue samples obtained as a result of surgical treatment, of which 85 samples of myomatous nodes and 48 samples of morphologically unchanged myometrium. All samples of myomptous nodes were analyzed for the presence of somatic mutation MED12 by Sanger sequencing. Using reverse transcription and polymerase chain reaction (PCR) methods. The expression profile of 17 candidate genes (PAPPA1, GRPR, TYMS, PLAG1, VCAN, AVPR1A, ESR1, PLA2R1, RANKL, KLF11, KRT19, MMP11, ADAM12, MMP16, PCP4, SATB2, WIF1), presumably involved in the pathogenesis of uterine fibroids, selected based on bioinformatic analysis, was studied. For histological examination, sections with a thickness of 5 microns were obtained from paraffin blocks and stained with hematoxylin and eosin. An immunohistochemical study was performed to determine the surrogate molecular subtype of leiomyoma samples. Results and discussion. This report presents data indicating that for different molecular phenotypes of uterine fibroids associated and not associated with somatic mutations in the MED12 gene (MED12+ and MED12–, respectively), the expression profile of certain genes is significantly different. Hyperexpression of the HMGA2 gene is observed in some myomatous nodes with the molecular phenotype MED12–, and in some — decreased expression of the HMGA2 gene. The expression profile of other candidate genes in myomatous nodes of MED12– with increased/decreased expression of the HMGA2 gene also differs. In addition, according to immunohistochemical studies, hypervascularization and increased cellularity are detected in 39% of samples of myomatous nodes with the molecular phenotype MED12– and HMGA2+ more often than in samples of myomatous nodes with the molecular phenotype MED12– and HMGA2.

  • Heterogeneity of the molecular phenotype with uterine fibroids. Message I

    by L.V. Akulenko, E.A. Nersesyan, M.V. Kuznetsova, T.A. Chernyshenko, F.V. Nenakhov, N.M. Tonoyan, G.V. Mikhailovskaya, K.A. Svirepova, P.I. Rasner, D.Yu. Trofimov


  • Open Access

    Contemporary insights into rehabilitation of cervical cancer patients

    by D. V. Blinov, A. G. Solopova, E. E. Achkasov, D. I. Korabelnikov, S. A. Akavova, V. N. Galkin, Ph. V. Nenakhov, G. K. Bykovshchenko, D. A. Petrenko

    Cancer prevalence particularly for cervical cancer (CC) has been steadily increasing tending to rise among young women. Vigorous antitumor treatment approaches employed in CC management have detrimental effects on various aspects of a woman's life. In addition to causing morphofunctional alterations in diverse host organs and systems, such treatment protocols result in psychological and emotional disturbances, sexual dysfunction, and social maladjustment, which collectively profoundly reduce the quality of life (QoL). Integrating timely rehabilitation programs into comprehensive care of such patients can effectively alleviate or minimize complications related to antitumor treatment, improve QoL, and restore a woman's desire for satisfying sexual and social engagement.


  • The results of colorectal resection for bowel deep infiltrating endometriosis

    by A.L. Goncharov, M.A. Chicherina, T.A. Chernyshenko, F.A. Levshin, F.V. Nenakhov, A.M. Kabeshov, N.S. Zhakiyev, E.A. Gallyamov

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить непосредственные результаты сегментарных резекций кишечника у пациенток с колоректальным эндометриозом. МАТЕРИАЛ И МЕТОДЫ В ретроспективное исследование включены 60 пациенток с диагнозом глубокого инфильтративного эндометриоза, которым проведено хирургическое лечение в объеме сегментарной резекции кишечника в период с 2016 по 2022 г. РЕЗУЛЬТАТЫ Все операции выполнены двумя бригадами специалистов: гинекологов с большим опытом лечения глубокого эндометриоза и колопроктологов. 59 операций выполнены лапароскопическим доступом и одна операция — открытым доступом. Среднее время операции составило 263,5±86,0 мин, кровопотеря — 126,1 (10—400) мл. Интраоперационные осложнения отсутствовали. Конверсий при выполнении лапароскопических операций не было. Превентивная стома не формировалась ни в одном случае. Послеоперационный койко-день составил 7,5±4,2. Функция кишечника восстанавливалась в среднем через 4,3±3,1 дня. Послеоперационные осложнения выявлены у 7 (11,6%) пациенток. Несостоятельность анастомоза имела место в 1 (1,6%) случае. Дизурические расстройства, требующие повторной катетеризации мочевого пузыря, возникли у 2 (3,3%) больных. ЗАКЛЮЧЕНИЕ Применение малоинвазивного мультидисциплинарного подхода позволяет выполнить необходимый объем операции с иссечением всех пораженных эндометриозом тканей с низким уровнем осложнений и отсутствием конверсий.